Searched for
FDA APPROVE
Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chains- $10. 6 billion deal: GSK to buy US cancer specialist Nuvalent
- Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse
- In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...06 Jun, 2026, 06.04 PM IST
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...02 Jun, 2026, 07.31 PM IST
- In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...02 Jun, 2026, 05.21 PM IST
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...02 Jun, 2026, 11.10 AM IST
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...02 Jun, 2026, 05.48 AM IST
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...02 Jun, 2026, 12.05 AM IST
- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...01 Jun, 2026, 12.09 PM IST
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...01 Jun, 2026, 11.51 AM IST
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....01 Jun, 2026, 10.11 AM IST
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...01 Jun, 2026, 07.44 AM IST
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...31 May, 2026, 05.00 PM IST
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...30 May, 2026, 12.52 AM IST
- How to identify Gaboon Viper: Key physical features, range, habitat, and dietAfrica's Gaboon viper boasts the longest fangs of any venomous snake. This master of camouflage lives in forests and is a patient hunter. W...29 May, 2026, 03.22 PM IST
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...28 May, 2026, 09.51 PM IST
- Tata Elxsi unveils AnaTel, an AI-powered platform for healthcare software engineering and regulatory complianceTata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...28 May, 2026, 04.14 PM IST
- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...23 May, 2026, 11.36 AM IST
Load More
